Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |